Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

The price-to-earnings (P/E) ratio is a financial metric that divides a stock's price by its earnings per share (EPS) as a quick way to assess a company's valuation. A lower P/E ratio suggests the ...

Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...

In the latest trading session, Merck (MRK) closed at $89.23, marking a +1.86% move from the previous day. This move outpaced the S&P 500's daily loss of 1.97%. Meanwhile, the Dow experienced a ...

Merck (MRK) Q3 results: Revenues: $10,794M (+4.5%); Net Income: $1,950M; Non-GAAP Net Income: $3,178M (+4.1%); EPS: $0.73;... Dynavax Technologies (NASDAQ:DVAX) is up 18% premarket on light volume ...

The general mood among these heavyweight investors is divided, with 63% leaning bullish and 36% bearish. Among these notable ...

Mylan N.V. (MYL +0.5%) announces the U.S. commercial launch of perphenazine tablets, the generic version of Merck (NYSE:MRK)'s ...